Logo
x

Search

Subscribe Now

Eli Lilly

Eli Lilly Receives the US FDA’s Approval for Omvoh (Mirikizumab-mrkz) to Treat Crohn's Disease (CD)

Eli Lilly Receives the US FDA’s Approval for Omvoh (Mirikizumab-mrkz) to Treat Crohn's Disease (CD)

  • January 16, 2025
Eli Lilly Inks ~2.5B Deal to Acquire Scorpion Therapeutics

Eli Lilly Inks ~2.5B Deal to Acquire Scorpion Therapeutics

  • January 14, 2025
Eli Lilly Reports the US FDA’s Approval of Zepbound (Tirzepatide) to Treat Moderate-to-Severe Obstructive Sleep Apnea in Obese Adults

Eli Lilly Reports the US FDA’s Approval of Zepbound (Tirzepatide) to Treat Moderate-to-Severe Obstructive Sleep Apnea in Obese Adu...

  • December 23, 2024
Eli Lilly Reports Kinsula (Donanemab-Azbt) Approval in China to Treat Early Symptomatic Alzheimer's Disease

Eli Lilly Reports Kinsula (Donanemab-Azbt) Approval in China to Treat Early Symptomatic Alzheimer's Disease

  • December 19, 2024
Eli Lilly Reports the CHMP’s Positive Opinion of Omvoh (Mirikizumab) to Treat Moderate to Severe Active Crohn's Disease

Eli Lilly Reports the CHMP’s Positive Opinion of Omvoh (Mirikizumab) to Treat Moderate to Severe Active Crohn's Disease

  • December 16, 2024
Eli Lilly Reports the P-III (EMBER-3) Trial Results of Imlunestrant to Treat ER+/HER2- Advanced Breast Cancer

Eli Lilly Reports the P-III (EMBER-3) Trial Results of Imlunestrant to Treat ER+/HER2- Advanced Breast Cancer

  • December 12, 2024
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2025 PharmaShots - All Rights Reserved.